Based on the company's latest reports for March 2026, the current 12-month EPS is -$22.8. Teleflex's earnings per share in 2025 was reported at -$20.3, marking a decline from $1.49 in 2024. In the quarterly report ending on Mar 31, 2026, TFX's earnings per share amounted to -$0.18.
Teleflex had an yealy earnings per share of -$20.3, showing a decline of 1,462.4% from $1.49 recorded in 2024. The quarterly earnings per share for the period ending Mar 31, 2026, was -$0.18, showing a 108.7% decline compared to the same quarter last year. The trailing twelve months EPS for TFX is -$22.8 as of March 2026. Teleflex's full-year EPS for 2024 was $1.49, a 80.3% decline compared to the previous year.
Teleflex has recorded a decline in earnings per share of 108.7% in the past 12 months (YoY, quarterly).
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| BSX Boston Scientific Corp | 18.83 | 55.6% | 63.3% | N/A |
| JNJ Johnson & Johnson | 27.19 | 90.6% | 17.7% | 14.8% |
| MMSI Merit Medical Systems Inc | 28.64 | 4.8% | 18.3% | N/A |
| BDX Becton Dickinson & Co | 36.69 | -0.9% | -0.6% | 16.2% |
| GE General Electric Co | 43.68 | 35.8% | 447.4% | 12.1% |
| COO Cooper Companies Inc | 55.55 | -4.6% | -1.2% | 9.2% |
| ANGO Angiodynamics Inc | N/A | 81.9% | N/A | N/A |
| IART Integra Lifesciences Holdings Corp | N/A | -7,388.9% | N/A | N/A |
| TFX Teleflex Inc | N/A | -1,462.4% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.